Share Price:

APNASPENAspen Pharmacare Hldgs13252-517 (-3.75%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

A United Approach to Tackling Obesity

Obesity is far more than a medical condition — it is a complex societal challenge that affects individuals, families, communities, and the broader healthcare system in South Africa. Its growing prevalence is shaped by a mix of biological, environmental, and socioeconomic factors, making it an issue that cannot be addressed through personal effort alone.

In response, Aspen Pharmacare has adopted a coordinated and proactive approach to obesity awareness and support. Through strong partnerships, community-focused education, and accessible healthcare interventions, Aspen is empowering South Africans with the tools and information they need to make informed decisions about their health.


Hear from Stavros Nicolaou, Group Senior Executive at Aspen Pharmacare Holdings Limited, as he explains how Aspen is championing this united effort.

Facebook
Twitter
LinkedIn
Pinterest

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: